What is the price-to-earnings ratio of Resmed?
The price-earnings ratio of Resmed is currently 6.53.
Resmed P/S 2024
Resmed P/S
6.53
Ticker
RMD
ISIN
US7611521078
WKN
895878
As of Nov 29, 2024, Resmed's P/S ratio stood at 6.53, a -14.53% change from the 7.64 P/S ratio recorded in the previous year.
The Resmed P/S history
Resmed Aktienanalyse
What does Resmed do?
ResMed Inc. is a global leading provider of medical devices for the treatment of sleep disorders and respiratory diseases. The company was founded in Australia by Peter Farrell, a former employee of the University of New South Wales, in 1989. Today, ResMed is headquartered in San Diego, California, and employs over 7,500 people worldwide. Business model: ResMed's business model is based on providing medical products and solutions for the treatment of sleep apnea and other respiratory diseases. The company develops and distributes masks, devices, and accessories that help patients breathe better and achieve restful sleep. ResMed also offers cloud-based software solutions and services to assist doctors and sleep labs in diagnosing and monitoring patients. Products and divisions: ResMed's product range can be divided into four main divisions: Sleep & Respiratory Care, Software as a Service (SaaS), Technologies, and Dental Solutions. Sleep & Respiratory Care: In this division, ResMed offers a wide range of masks, devices, and accessories for the treatment of sleep apnea and other respiratory diseases. The most well-known products include the AirSense and AirMini devices, equipped with Automatic Sleep Detection and AutoSet algorithm to optimize respiratory pressure. ResMed also offers a range of CPAP masks, nasal and full face masks, as well as nasal pillow masks. Software as a Service (SaaS): ResMed's cloud-based software solutions and services are offered under the brand AirView. They include diagnostic tools, patient monitoring systems, and analysis tools. AirView allows doctors to access their patients' medical data captured by ResMed devices and monitor this data in real-time. Technologies: ResMed's Technologies division focuses on the development of advanced sensors for respiratory and sleep monitoring. Products include the S+, a smart sleep tracking system that operates without direct body contact, and the Reveal-LTE, an implant for monitoring heart and respiratory rates in patients with heart failure. Dental Solutions: ResMed has also developed products for dentistry to assist patients with mild to moderate upper airway obstruction. Products include the Narval CC, a custom-made dental device for the treatment of snoring and sleep apnea, and the Tap Pap nasal pillow oral appliance, a non-invasive mouthguard. Conclusion: ResMed is a leading provider of medical devices and solutions for the treatment of sleep apnea and other respiratory diseases. The company offers innovative products and technologies that help patients breathe better and achieve restful sleep. ResMed's cloud-based software solutions enable doctors to monitor their patients' health in real-time and develop effective diagnosis and treatment strategies. With its wide range of products, innovation, and highly qualified team of scientists, engineers, and medical professionals, ResMed will continue to play an important role in the healthcare industry. Resmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Resmed's P/S Ratio
Resmed's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Resmed's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Resmed's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Resmed’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Resmed stock
How has the price-earnings ratio of Resmed changed compared to last year?
The price-to-earnings ratio of Resmed has increased by -14.53% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Resmed high compared to other companies?
Yes, the price-to-earnings ratio of Resmed is high compared to other companies.
How does an increase in the price-earnings ratio of Resmed affect the company?
An increase in the price-earnings ratio of Resmed would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Resmed affect the company?
A decrease in the price-earnings ratio of Resmed would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Resmed?
Some factors that influence the price-earnings ratio of Resmed are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Resmed pay?
Over the past 12 months, Resmed paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resmed is expected to pay a dividend of 2.31 USD.
What is the dividend yield of Resmed?
The current dividend yield of Resmed is .
When does Resmed pay dividends?
Resmed pays a quarterly dividend. This is distributed in the months of March, June, September, December.
How secure is the dividend of Resmed?
Resmed paid dividends every year for the past 0 years.
What is the dividend of Resmed?
For the upcoming 12 months, dividends amounting to 2.31 USD are expected. This corresponds to a dividend yield of 0.93 %.
In which sector is Resmed located?
Resmed is assigned to the 'Health' sector.
Wann musste ich die Aktien von Resmed kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Resmed from 12/12/2024 amounting to 0.53 USD, you needed to have the stock in your portfolio before the ex-date on 11/7/2024.
When did Resmed pay the last dividend?
The last dividend was paid out on 12/12/2024.
What was the dividend of Resmed in the year 2023?
In the year 2023, Resmed distributed 1.84 USD as dividends.
In which currency does Resmed pay out the dividend?
The dividends of Resmed are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Resmed stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Resmed
Our stock analysis for Resmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
